Ghazala Naveed, Faraz Ahmed Bokhari


Background: Studies of homocysteine in vascular disorders have yielded conflicting data. There are also differences based on various ethnicities and cultures. In this study, we have examined the homocysteine patterns in local stroke patients, so as to ascertain the homocysteine status in a sample of local population. Homocysteine-white matter hypodensities relationship in stroke is emerging, as an important aspect in stroke pathophysiology and is thought to have prognostic and therapeutic values. Methods: We included 150 stroke patients who were diagnosed as having clinical stroke on the basis of history; physical examination and CT (Computerized Tomography) scan of brain. These patients were recruited from neurology and emergency wards of two public sector hospitals of Lahore. The presence or absence of white matter hypodensities were diagnosed after consultation with a radiologist. Blood samples were collected from the same stroke patients. Results: We found a strong association between white matter hypodensities and total homocysteine in plasma of stroke patients p<0.001. Conclusion: Homocysteine is a risk factor for white matter hypodensities in stroke patients in our study.

Full Text:



American Heart Association. Heart Disease and Stroke Statistics—2003 Update. Dallas, Tex: American Heart Association; 2002.

McElveen WA, Alway D. Ischemic Stroke and Transient Ischemic Attack–Acute Evaluation and Management. In: Stroke Essentials for Primary Care. Springer; 2009. p.9–33.

Englund E. Neuropathology of white matter disease:parenchymal changes in Alzheimers disease and Vascular Dementia. Dement Geriatric Cogn Disord 1998;9(1 Suppl):6–12.

Wen W, Sachdev PS, Li JJ, Chen X, Anstey KJ. White Matter Hyperintensities in the Forties: Their Prevalence and Topography in an Epidemiological Sample Aged 44–48. Human Brain Mapp 2009;30(4):1155–67.

Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28(3):652–9.

Sachdev PS, Wei W, Christensen H, Jorm AF. White matter hyperintensities are related to physical disability and poor motor function. J Neurol Neurosurg. Psychiatry 2005;76(3):362–7.

Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain MRI: systematic review and meta-analysis, BMJ 2010;341.

McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56(1):111–28.

Spence JD, Bang H, Chambless LE, Stampfer MJ. Vitamin Intervention For Stroke Prevention trial: an efficacy analysis. Stroke 2005;36(11):2404–9.

Tseng YL, Chang YY, Liu JS, Su CS, Lai SL, Lan MY. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients. J Neurol Sci 2009;284(1-2):36–9.

Wen W, Sachdev PS. Extent and distribution of white matter hyperintensities in stroke patients: the sydney stroke study. Stroke 2004;35(12):2813–9.

Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002;51(3):285–9.

Anan F, Masaki T, Tatsukawa H, Nagano S, Oribe M, Eshima N, et al. The role of homocysteine as a significant risk factor for white matter lesions in Japanese women with rheumatoid arthritis. Metabolism 2009;58(1):69–73.

Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, et al. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 2008;65(5):642–9.

Dufouil C, Alpérovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53(2):214–21.

Longstreth WT Jr, Katz R, Olson J, Bernick C, Carr JJ, Malinow MR, et al. Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study. Arch Neurol 2004;61(1):67–72.

Kohara K, Fujisawa M, Ando F, Tabara Y, Niino N, Miki T, et al. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study. Stroke 2003;34(5):1130–5.

Bostom AG, Rosenberg IH, Silbershatz H, Jacgues PF, Selhub J, D’Agostino RB, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999;131(5):352–5.

Naureen A, Munazza B, Shaheen R, Khan SA, Fatima F. Serum homocysteine as a risk factor for coronary heart disease. J Ayub Med Coll Abbottabad. 2012;24(1):59-62.


  • There are currently no refbacks.

Contact Number: +92-992-382571

email: [jamc] [@] []